Neurocrine Biosciences (NBIX) Tops Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Neurocrine Biosciences (NBIX) Tops Q4 EPS by 2c

Neurocrine Biosciences Reports Fourth Quarter and Year-End 2018 Financial Results

February 5, 2019 4:01 PM EST

SAN DIEGO, Feb. 5, 2019 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended December 31, 2018 and provided an update on the launch of INGREZZA® (valbenazine) and its clinical development programs.

"We are extremely proud of what we have accomplished since INGREZZA was approved in... More